The Hanover Insurance
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions increased by 21 in the most recent period (2026/Q3).
- Total institutional ownership rose 1.6 percentage points.
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Institutional ownership
- Held by institutions
- 94.10% +1.58pp
- Institutions
- 642 +21
- As of
- 2026/Q3 vs. prior period
Holder types
Top holders as of 2026-09-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 37 buys · 13 sells
| Name | Role | Stake |
|---|---|---|
| John Roche | Chief Executive Officer | 0.37% |
| Jeffrey Farber | Chief Financial Officer | 0.17% |
| Joseph Ramrath | Independent Director | 0.10% |
| Richard Lavey | Chief Operating Officer | 0.08% |
| Bryan Salvatore | Executive VP & President of Specialty | 0.07% |
| Cynthia Egan | Independent Chairperson & Independent Presiding Director | 0.03% |
| Kevin Bradicich | Independent Director | 0.03% |
| Dennis Kerrigan | Executive VP, Chief Legal Officer, Corporate Secretary & Interim Chief Human Resources Officer | 0.02% |
| Willard Lee | Executive VP and Chief Information & Innovation Officer | 0.02% |
| James Condrin | Independent Director | 0.02% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-11-11 | John Roche | Chief Executive Officer | Derivative Exercise and Sale | -74,620 | $104.11–250.00 |
| 2026-11-11 | John Roche | Chief Executive Officer | Intent to Sell (Form 144) | -14,422 | $249.39 |
| 2026-11-10 | John Roche | Chief Executive Officer | Derivative Exercise and Retained | +9,971 | $104.11 |
| 2026-11-03 | Theodore Bunting | Independent Director | Other Disposition | -450 | -- |
| 2026-11-03 | Willard Lee | Executive VP and Chief Information & Innovation Officer | Open Market Disposition | -60 | $249.69 |
| 2026-11-03 | Willard Lee | Executive VP and Chief Information & Innovation Officer | Derivative Exercise and Sale | -9,886 | $115.35–249.69 |
| 2026-09-24 | Joseph Ramrath | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Kathleen Lane | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Theodore Bunting | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Jeffrey Farber | Chief Financial Officer | Other Acquisition | +41 | -- |
| 2026-09-24 | Richard Lavey | Chief Operating Officer | Other Acquisition | +27 | -- |
| 2026-09-24 | William Donnell | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Elizabeth A. Chicares | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Cynthia Egan | Independent Chairperson & Independent Presiding Director | Other Acquisition | +3 | -- |
| 2026-09-24 | John Roche | Chief Executive Officer | Other Acquisition | +120 | -- |
| 2026-09-24 | Bryan Salvatore | Executive VP & President of Specialty | Other Acquisition | +24 | -- |
| 2026-09-24 | Dennis Kerrigan | Executive VP, Chief Legal Officer, Corporate Secretary & Interim Chief Human Resources Officer | Other Acquisition | +14 | -- |
| 2026-09-24 | James Condrin | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Francisco Aristeguieta Silva | Independent Director | Other Acquisition | +3 | -- |
| 2026-09-24 | Jane Carlin | Independent Director | Other Acquisition | +3 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
The Hanover Insurance discussion 0 comments